Back for its 11th Annual edition, this global bio-pharma industry forum addresses through its conference programme the main challenges for 2018 in investment, partnering and alliance management. Key players contribute their insights in panels which cover the macro picture as well as innovation in the different therapeutic sectors. The Forum also features keynote speeches by KOL, about 60 selected corporate presentations from established (public and private) and emerging biotechs seeking to promote investment and partnering opportunities.

Dr Dirk Beher will be panellist on the “Neuroscience Advanced Therapies and Diagnostics Panel ” on February 26th, at 12:15 PM. Dr Beher will also make a company presentation on February 26th, at 2:00 PM.

Asceneuron is featured in a BioCentury emerging company profile by Emily Cukier-Meisner, in the article “The road to Tau” published in March 2015.

An exceptional and unexpected outcome of the 2014 edition of the Universal Biotech Innovation Prize has surprised the audience: the 6th edition has 2 winners, one best Biotech project and one best Medtech project.

CurePSP is the foremost non-profit organization dedicated to increasing awareness of progressive supranuclear palsy (PSP), corticobasal degeneration (CBD), and other atypical Parkinsonian disorders; funding research toward treatment, cure and prevention; educating healthcare professionals; and providing support, information and hope for affected persons and their families.